-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Hims & Hers Health, Raises Price Target to $65

Benzinga·06/04/2025 10:54:02
Listen to the news
Needham analyst Ryan MacDonald maintains Hims & Hers Health (NYSE:HIMS) with a Buy and raises the price target from $61 to $65.